Sagittarius Life Science Corp (TPEX:3205)
Taiwan · Delayed Price · Currency is TWD 51.30
-1.00 (-1.91%)
Nov 3, 2025, 1:30 PM CST
Sagittarius Life Science Market Cap
Sagittarius Life Science has a market cap or net worth of 3.47 billion as of October 31, 2025. Its market cap has increased by 185.44% in one year.
Market Cap
3.47B
Enterprise Value
2.66B
Revenue
446.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
51.30
Market Cap Chart
Since May 2, 2006, Sagittarius Life Science's market cap has increased from 288.69M to 3.47B, an increase of 1,100.29%. That is a compound annual growth rate of 13.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 3.53B | 239.73% |
| Dec 31, 2024 | 1.04B | -38.79% |
| Dec 29, 2023 | 1.70B | 28.26% |
| Dec 30, 2022 | 1.32B | 48.00% |
| Dec 30, 2021 | 895.00M | -19.59% |
| Dec 31, 2020 | 1.11B | -34.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 233.43B |
| PharmaEssentia | 184.18B |
| Lotus Pharmaceutical | 77.71B |
| Bora Pharmaceuticals Co., LTD. | 77.08B |
| Lumosa Therapeutics | 35.38B |
| Oneness Biotech | 30.99B |
| Pegavision | 26.56B |
| Polaris Group | 26.43B |